ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Down 4.7% – Should You Sell?

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s share price was down 4.7% on Monday. The company traded as low as $15.15 and last traded at $15.30. Approximately 3,335 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 227,400 shares. The stock had previously closed at $16.05.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CHRN. Compass Point assumed coverage on ChronoScale Corporation Common Stock in a report on Friday. They issued a “buy” rating and a $25.00 target price for the company. Northland Securities assumed coverage on shares of ChronoScale Corporation Common Stock in a report on Friday, September 18th. They set an “outperform” rating and a $32.00 price target for the company. Finally, Weiss Ratings upgraded shares of ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research report on Friday, October 9th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $21.00.

ChronoScale Corporation Common Stock Trading Up 3.2%

The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.30 and a current ratio of 0.30. The stock has a market cap of $2.27 billion, a price-to-earnings ratio of -2.89 and a beta of 0.98. The business has a fifty day simple moving average of $19.78 and a 200 day simple moving average of $18.23.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its earnings results on Wednesday, October 14th. The company reported ($0.29) earnings per share (EPS) for the quarter. The firm had revenue of $41.48 million during the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 66.16%. As a group, equities analysts anticipate that ChronoScale Corporation Common Stock will post -0.39 EPS for the current year.

Hedge Funds Weigh In On ChronoScale Corporation Common Stock

An institutional investor recently raised its stake in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc lifted its position in shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,338 shares of the company’s stock after buying an additional 1,195 shares during the period. Roble Belko & Company Inc owned approximately 0.07% of ChronoScale Corporation Common Stock worth $25,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 6.42% of the company’s stock.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.